These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35026315)

  • 1. Improving the dissolution behaviors and bioavailability of abiraterone acetate via multicomponent crystal forms.
    Yang Z; Yang Y; Xia M; Dai W; Zhu B; Mei X
    Int J Pharm; 2022 Feb; 614():121460. PubMed ID: 35026315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds.
    Shiraki K; Takata N; Takano R; Hayashi Y; Terada K
    Pharm Res; 2008 Nov; 25(11):2581-92. PubMed ID: 18651208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of abiraterone acetate oral bioavailability by supersaturated-silica lipid hybrids.
    Schultz HB; Wignall AD; Thomas N; Prestidge CA
    Int J Pharm; 2020 May; 582():119264. PubMed ID: 32278053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glibenclamide-malonic acid cocrystal with an enhanced solubility and bioavailability.
    Srivastava D; Fatima Z; Kaur CD; Mishra A; Nashik SS; Rizvi DA; Prasad R
    Drug Dev Ind Pharm; 2022 Aug; 48(8):417-424. PubMed ID: 36073946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Novel Palbociclib-Resorcinol and Palbociclib-Orcinol Cocrystals with Enhanced Solubility and Dissolution Rate.
    Duan C; Liu W; Tao Y; Liang F; Chen Y; Xiao X; Zhang G; Chen Y; Hao C
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Sodium Mefenamate - Nicotinamide Multicomponent Crystal Development to Modulate Solubility and Dissolution: Preparation, Structural, and Performance Study.
    Nugrahani I; Fisandra F; Horikawa A; Uekusa H
    J Pharm Sci; 2021 Sep; 110(9):3246-3260. PubMed ID: 34090898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation.
    Diniz LF; Carvalho PS; Souza MAC; Diniz R; Fernandes C
    Mol Pharm; 2024 Jul; 21(7):3661-3673. PubMed ID: 38858241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quabodepistat (OPC-167832), a Novel Antituberculosis Drug Candidate: Enhancing Oral Bioavailability via Cocrystallization and Mechanistic Analysis of Bioavailability in Two Cocrystals.
    Sakamoto N; Miyata K; Fukami T
    Mol Pharm; 2024 Jan; 21(1):358-369. PubMed ID: 38099729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations of the mechanism behind the rapid absorption of nano-amorphous abiraterone acetate.
    Basa-Dénes O; Solymosi T; Ötvös Z; Angi R; Ujhelyi A; Jordán T; Heltovics G; Glavinas H
    Eur J Pharm Sci; 2019 Mar; 129():79-86. PubMed ID: 30610953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization, and pharmacokinetics of rivaroxaban cocrystals with enhanced in vitro and in vivo properties in beagle dogs.
    Meng Y; Tan F; Yao J; Cui Y; Feng Y; Li Z; Wang Y; Yang Y; Gong W; Yang M; Kong X; Gao C
    Int J Pharm X; 2022 Dec; 4():100119. PubMed ID: 35663355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements.
    Solymosi T; Ötvös Z; Angi R; Ordasi B; Jordán T; Semsey S; Molnár L; Ránky S; Filipcsei G; Heltovics G; Glavinas H
    Int J Pharm; 2017 Oct; 532(1):427-434. PubMed ID: 28919099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the solubility and permeability of the diuretic drug furosemide via multicomponent crystal forms.
    Diniz LF; Carvalho PS; Pena SAC; Gonçalves JE; Souza MAC; de Souza Filho JD; Bomfim Filho LFO; Franco CHJ; Diniz R; Fernandes C
    Int J Pharm; 2020 Sep; 587():119694. PubMed ID: 32726610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rucaparib cocrystal: Improved solubility and bioavailability over camsylate.
    Xia M; Jiang Y; Cheng Y; Dai W; Rong X; Zhu B; Mei X
    Int J Pharm; 2023 Jan; 631():122461. PubMed ID: 36462737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azilsartan-nicotinamide cocrystal: Preparation, characterization and in vitro / vivo evaluation.
    Xiao Y; Jin T; Geng X; Zhu X
    Eur J Pharm Sci; 2022 Sep; 176():106241. PubMed ID: 35716990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supersaturated-Silica Lipid Hybrids Improve in Vitro Solubilization of Abiraterone Acetate.
    Schultz HB; Joyce P; Thomas N; Prestidge CA
    Pharm Res; 2020 Mar; 37(4):77. PubMed ID: 32236761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug.
    Srivastava D; Fatima Z; Kaur CD; Tulsankar SL; Nashik SS; Rizvi DA
    Recent Pat Drug Deliv Formul; 2019; 13(1):62-69. PubMed ID: 30848223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the solubility and bioavailability of anti-hepatitis B drug PEC
    Li L; Yin XH; Diao KS
    RSC Adv; 2020 Sep; 10(59):36125-36134. PubMed ID: 35517067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.